Bastide Le Confort Medical


Integration of the FY17/18 figures

10/01/19 -"We have integrated the FY 17/18 figures. The solid growth momentum has continued to be supported by the solid demand from the increasing number of elderly European people and an accelerating net ..."

Pages
43
Language
English
Published on
10/01/19
You may also be interested by these reports :
18/01/19
Since our last teasing piece on the beleaguered Swedish medtech player in January 2018 [Get(t)ing(e) value or just window dressing], Getinge (Reduce, ...

17/01/19
2018 started-off on a positive note for ophthalmic lens developer, Essilor. Robust acceleration in organic sales in Q4 17 (+5.1% vs. 9M 17: +2.5%) ...

10/01/19
We have integrated the FY 17/18 figures. The solid growth momentum has continued to be supported by the solid demand from the increasing number of ...

04/01/19
Ups and Downs As in October and November, the negative momentum continued for the MedTech sector in the last month of 2018 as well, though it ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO